France
# |
Name |
Price to Book Ratio (P/B) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
48.22 |
Jan. 14, 2025 | USD 1.94 | -0.97% |
|
France |
|
2 |
29.64 |
Jan. 14, 2025 | USD 4.25 | 1.59% |
|
France |
|
3 |
6.96 |
Jan. 14, 2025 | USD 208.18 | -0.28% |
|
France |
|
4 |
6.04 |
Jan. 14, 2025 | USD 6.91 | 0.46% |
|
France |
|
5 |
5.27 |
Jan. 14, 2025 | USD 8.53 | 3.61% |
|
France |
|
6 |
5.11 |
Jan. 14, 2025 | USD 1.29 | -1.75% |
|
France |
|
7 |
3.16 |
Jan. 14, 2025 | USD 110.89 | -1.59% |
|
France |
|
8 |
2.75 |
Jan. 14, 2025 | USD 1.88 | -0.49% |
|
France |
|
9 |
2.40 |
Jan. 14, 2025 | USD 122.64 | 0.35% |
|
France |
|
10 |
2.33 |
Jan. 14, 2025 | USD 3.40 | -0.30% |
|
France |
|
11 |
2.11 |
Jan. 14, 2025 | USD 1.74 | -2.29% |
|
France |
|
12 |
2.02 |
Jan. 14, 2025 | USD 2.16 | 6.70% |
|
France |
|
13 |
1.93 |
Jan. 14, 2025 | USD 6.25 | -0.54% |
|
France |
|
14 |
1.92 |
Jan. 14, 2025 | USD 3.97 | 0.60% |
|
France |
|
15 |
1.60 |
Jan. 14, 2025 | USD 1.42 | -0.83% |
|
France |
|
16 |
1.42 |
Jan. 13, 2025 | USD 20.08 K | 0.04% |
|
France |
|
17 |
1.35 |
Jan. 14, 2025 | USD 26.07 | 0.60% |
|
France |
|
18 |
1.20 |
Jan. 14, 2025 | USD 1.53 | 0.60% |
|
France |
|
19 |
1.10 |
Jan. 14, 2025 | USD 1.50 | -9.33% |
|
France |
|
20 |
0.74 |
Jan. 14, 2025 | USD 1.95 | -2.23% |
|
France |
|
21 |
0.65 |
Jan. 14, 2025 | USD 1.82 | 1.18% |
|
France |
|
22 |
0.46 |
Jan. 14, 2025 | USD 0.68 | -1.49% |
|
France |
|
23 |
0.42 |
Jan. 14, 2025 | USD 6.44 | -3.56% |
|
France |
|
24 |
0.19 |
Jan. 14, 2025 | USD 2.27 | 11.78% |
|
France |
|
25 |
0.00 |
Jan. 14, 2025 | USD 0.96 | -6.39% |
|
France |
|
26 |
-6.18 |
Jan. 14, 2025 | USD 2.29 | 4.37% |
|
France |
|
27 |
-11.27 |
Jan. 14, 2025 | USD 16.86 | 0.98% |
|
France |
|
28 |
-12.46 |
Jan. 14, 2025 | USD 6.08 | 1.81% |
|
France |
|
29 |
-71.43 |
Jan. 14, 2025 | USD 3.05 | 0.95% |
|
France |
The Biotechnology company in France with the highest Price to Book Ratio (P/B) is NFL Biosciences SA (Paris Stock Exchange: ALNFL.PA) at 48.22.
The Biotechnology company in France with the lowest Price to Book Ratio (P/B) is Nanobiotix S.A. (Paris Stock Exchange: NANO.PA) at -71.43.
The top 10 Biotechnology companies in France by Price to Book Ratio (P/B) are NFL Biosciences SA, Predilife S.A., Sartorius Stedim Biotech S.A., OSE Immunotherapeutics SA, MaaT Pharma SA, ABIONYX Pharma SA, bioMérieux S.A., Innate Pharma S.A., Ipsen S.A. and Genfit S.A..
The bottom 10 Biotechnology companies in France by Price to Book Ratio (P/B) are Nanobiotix S.A., Adocia SA, MedinCell S.A., Inventiva S.A., Neovacs S.A., Biosynex SA, Carbios SAS, Novacyt S.A., PHAXIAM Therapeutics S.A. and AFYREN SAS.